Investors don’t seem to be getting tired of the Donald Trump stock market rally as it rages into its third-straight week.
Stocks blasted higher into new high ground during the week as the reality of Donald Trump being the next president sinks in following the Nov. 8 election. As long as investors stuck with U.S. stocks and avoided shares of European companies or those in emerging markets as well as government debt it’s been difficultto lose money from the Trump rally. President-elect Trump has vowed to boost U.S. manufacturing by lowering U.S. tax rates and bust global trade agreements, while borrowing more to spend on infrastructure projects.
“Investors are embracing the promise of what may be and ignoring all of the risks. Trumphoria reigns,” says Michael Farr, president of money management firm Farr, Miller & Washington. “While lower taxes for corporations and individuals, infrastructure spending and less regulation would be welcome, they are at least a year in the making.”
Top Heal Care Stocks To Watch Right Now: UFP Technologies Inc.(UFPT)
- [By Joseph Griffin]
UFP Technologies (NASDAQ: UFPT) and China XD Plastics (NASDAQ:CXDC) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.
Top Heal Care Stocks To Watch Right Now: Papa Murphy's Holdings, Inc.(FRSH)
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested shorting small cap Take ‘N’ Bake pizza chain stock Papa Murphy’s Holdings (NASDAQ: FRSH):
- [By Peter Graham]
The Q4 earnings report forsmall cap Take ‘N’ Bake pizza chain stock Papa Murphy’s Holdings (NASDAQ: FRSH) is scheduled for after the market closes on Wednesday (March 15th). In February, our Under the Radar Moversnewsletter suggested shorting the stock by saying:
Top Heal Care Stocks To Watch Right Now: Trinity Biotech plc(TRIB)
- [By Max Byerly]
Trinity Biotech (NASDAQ: TRIB) is one of 25 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Trinity Biotech to related businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, profitability and institutional ownership.